Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Naimish Patel currently holds 19,357 shares of CRISPR Therapeutics AG (CRSP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Naimish Patel has been a net seller of CRSP stock. They have purchased $49.7K and sold $210.6K worth of shares.
Naimish Patel's most recent insider trade was on May 29, 2026, when they sold 3,786 shares at $55.62 per share.
Naimish Patel serves as Executive at CRISPR Therapeutics AG (CRSP). They have executed 7 insider transactions totaling $260.3K over their tenure at the company.
Naimish Patel holds the position of Executive at CRISPR Therapeutics AG, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Naimish Patel has shown a selling trading pattern, with $49.7K in total purchases and $210.6K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Naimish Patel was on May 29, 2026, when they sold $210.6K worth of CRSP shares. This transaction involved 3,786 shares at $55.62 per share.
Naimish Patel currently owns 19,357 shares of CRISPR Therapeutics AG (CRSP), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Naimish Patel's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Naimish Patel has 7 Form 4 filings on record as an insider at CRISPR Therapeutics AG.
Set alerts for Naimish Patel and 40,000+ other insiders.